造影剤の世界市場分析・予測...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 11
1.2 List of Figures 16
2 Industry Overview 21
2.1 Principles of Diagnostic X-ray Imaging 21
2.2 CT Contrast Media 23
2.2.1 Overview 23
2.2.2 Positive Contrast Media 23
2.2.3 Negative Contrast Media 28
2.3 Principles of Diagnostic Magnetic Resonance Imaging 29
2.4 MRI Contrast Media 31
2.4.1 Overview 31
2.4.2 Biodistribution 33
2.5 Principles of Diagnostic Ultrasound Imaging 35
2.6 Ultrasound Contrast Media 37
2.6.1 Overview 37
2.7 Safety Considerations 37
2.7.1 General Safety 37
2.7.2 Viscosity 39
2.7.3 Osmolality 40
2.7.4 Strength 40
2.7.5 Linear Versus Macrocyclic 41
2.7.6 Ultrasound Contrast Safety 43
2.8 Market Access and Reimbursement 43
2.8.1 Overview 43
2.8.2 US 44
2.8.3 5EU 45
2.8.4 APAC 49
2.8.5 Brazil 53
2.9 Market Volume 54
2.9.1 Global 54
2.9.2 US 64
2.9.3 5EU 69
2.9.4 France 72
2.9.5 Germany 78
2.9.6 Italy 84
2.9.7 Spain 89
2.9.8 UK 93
2.9.9 APAC 97
2.9.10 Japan 100
2.9.11 China 106
2.9.12 India 111
2.9.13 Brazil 114
3 Competitive Assessment 120
3.1 Overview 120
3.2 CT Contrast Media 120
3.2.1 Overview 120
3.3 MRI Contrast Media 128
3.3.1 Overview 128
3.4 Ultrasound Contrast Media 131
3.4.1 Overview (Microbubbles) 131
3.5 Company Share Analysis 132
3.5.1 Global 132
3.5.2 North America 134
3.5.3 Europe 135
3.5.4 APAC 136
4 Pipeline Products 137
4.1 CT Contrast Media-Pipeline Products 137
4.1.1 Overview 137
4.2 MRI Contrast Media-Pipeline Products 139
4.2.1 Overview 139
4.3 Ultrasound Contrast Media-Pipeline Products 139
4.3.1 Overview 139
5 Mergers and Acquisitions 141
5.1 Guerbet and Mallinckrodt 141
6 Current and Future Players 143
6.1 Trends in Corporate Strategy 143
6.2 Company Profiles 144
6.2.1 AGFA Healthcare (Agfa-Gevaert) 144
6.2.2 AMAG Pharmaceuticals 146
6.2.3 Bayer 149
6.2.4 Bracco 151
6.2.5 GE Healthcare 154
6.2.6 Guerbet/Mallinckrodt 157
6.2.7 Lantheus Medical Imaging 160
6.2.8 Sanochemia 162
6.2.9 Other Companies 165
7 Market Drivers, Barriers, and Unmet Needs 168
7.1 Market Drivers 168
7.1.1 World’s Rising and Aging Population 168
7.1.2 Increased Disease Screening Practices 169
7.1.3 Rising Prevalence of Disease 169
7.1.4 Increased Financial Power of Developing Countries 171
7.1.5 Mainstay of Modern Medicine 171
7.1.6 Power Injectors and Prefilled Contrast Delivery 172
7.1.7 Ultrasound Contrast Media 173
7.2 Barriers 173
7.2.1 Safety Issues 173
7.2.2 Price Competition 174
7.2.3 Limited Innovation 175
7.2.4 The Price of Ultrasound Contrast Media 176
7.2.5 Alternative or More Powerful Imaging Modalities 177
7.2.6 Generic Contrast Media 178
7.3 Unmet Needs 179
7.3.1 Lower Injection Volumes 179
7.3.2 Reduced Adverse Reactions 180
7.3.3 New Contrast Media 180
8 Market Outlook and Forecast 182
8.1 Global 182
8.1.1 Global Overview 182
8.1.2 Global Overview by Region 187
8.1.3 Global Overview by Segment 188
8.2 US 191
8.2.1 Contrast Media Market by Segment 191
8.2.2 CT Contrast Media Market by Sub-segment 192
8.3 5EU 195
8.3.1 5EU Contrast Media Market by Segment 195
8.3.2 France 197
8.3.3 Germany 203
8.3.4 Italy 209
8.3.5 Spain 214
8.3.6 UK 218
8.4 APAC 222
8.4.1 APAC Contrast Media Market by Segment 222
8.4.2 Japan 224
8.4.3 China 230
8.4.4 India 235
8.5 Brazil 239
8.5.1 Contrast Media Market by Segment 239
8.5.2 CT Contrast Media by Sub-segment 240
8.5.3 MRI Contrast Media by Sub-segment 243
9 Appendix 246
9.1 Bibliography 246
9.2 Abbreviations 256
9.3 Report Methodology 260
9.3.1 Overview 260
9.3.2 Coverage 260
9.3.3 Primary Research-Key Opinion Leader Interviews 260
9.3.4 Primary Research Interviews-Physician and Industry Participants 261
9.3.5 Physician Survey 261
9.3.6 Expert Panel Validation 262
9.3.7 Secondary Research 262
9.4 Forecasting Methodology 264
9.5 Physicians and Specialists Included in This Study 265
9.6 About the Team 266
9.6.1 Analysts 266
9.6.2 David Brady, Director of Operations – Market Research 267
9.6.3 Tyler Fletcher, Global Head of Medical Devices 267
9.7 About GlobalData 268
9.8 Disclaimer 268